ETHZilla, formerly 180 Life Sciences, has undergone a radical transformation in the financial world. This biotech company is now dedicated to accumulating substantial cryptocurrency holdings and has amassed nearly $350 million in Ethereum, with plans to expand their portfolio further. Their strategy mirrors that of Strategy (MSTR), led by Michael Saylor, the largest corporate Bitcoin holder. ETHZilla’s move coincides with growing optimism for digital assets under the crypto-friendly Trump administration, placing them at the forefront of this new wave of investment in the cryptocurrency space. 180 Life Sciences is rebranding itself as a leader in the Ethereum ecosystem.